Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1–10.

Article  CAS  PubMed  Google Scholar 

Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006;42(Suppl 1):S35–9.

Article  CAS  PubMed  Google Scholar 

Moise-Broder PA, Forrest A, Birmingham MC, et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43(13):925–42.

Article  CAS  PubMed  Google Scholar 

Nielsen EI, Cars O, Friberg LE. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization. Antimicrob Agents Chemother. 2011;55(10):4619–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013;57(2):734–44.

Article  PubMed  PubMed Central  Google Scholar 

Wicha SG, Martson AG, Nielsen EI, et al. From therapeutic drug monitoring to model-informed precision dosing for antibiotics. Clin Pharmacol Ther. 2021;109(4):928–41.

Article  CAS  PubMed  Google Scholar 

Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835–64.

Article  PubMed  Google Scholar 

Abdelmessih E, Patel N, Vekaria J, et al. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis. Pharmacotherapy. 2022;42(9):741–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sheiner LB. Computer-aided long-term anticoagulation therapy. Comput Biomed Res. 1969;2(6):507–18.

Article  CAS  PubMed  Google Scholar 

Darwich AS, Polasek TM, Aronson JK, et al. Model-informed precision dosing: background, requirements, validation, implementation, and forward trajectory of individualizing drug therapy. Annu Rev Pharmacol Toxicol. 2021;61:225–45.

Article  CAS  PubMed  Google Scholar 

Polasek TM, Rostami-Hodjegan A, Yim DS, et al. What does it take to make model-informed precision dosing common practice? Report from the 1st Asian Symposium on Precision Dosing. AAPSJ. 2019;21(2):17.

Article  PubMed  Google Scholar 

Kantasiripitak W, Van Daele R, Gijsen M, et al. Software tools for model-informed precision dosing: How well do they satisfy the needs? Front Pharmacol. 2020;11:620.

Article  PubMed  PubMed Central  Google Scholar 

Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53.

Article  PubMed  PubMed Central  Google Scholar 

Hoddinott P. A new era for intervention development studies. Pilot Feasibility Stud. 2015;1:36.

Article  PubMed  PubMed Central  Google Scholar 

O’Cathain A, Croot L, Sworn K, et al. Taxonomy of approaches to developing interventions to improve health: a systematic methods overview. Pilot Feasibility Stud. 2019;5:41.

Article  PubMed  PubMed Central  Google Scholar 

Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374: n2061.

Article  PubMed  PubMed Central  Google Scholar 

Duncan E, O’Cathain A, Rousseau N, et al. Guidance for reporting intervention development studies in health research (GUIDED): an evidence-based consensus study. BMJ Open. 2020;10(4): e033516.

Article  PubMed  PubMed Central  Google Scholar 

Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348: g1687.

Article  PubMed  Google Scholar 

STRAMA. Dosing of Vancomyin iv [updated 22.05.2023]. https://strama-nationell.infosynk.se/category/allmant/Vwt7tLqY1RafSmJZgA4g. Accessed 18 Sept 2023.

Carland JE, Elhage T, Baysari MT, et al. Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose-recommendation software. Br J Clin Pharmacol. 2021;87(3):1215–33.

Article  PubMed  Google Scholar 

Yager RC, Taylor N, Stocker SL, et al. Would they accept it? An interview study to identify barriers and facilitators to user acceptance of a prescribing advice service. BMC Health Serv Res. 2022;22(1):514.

Article  PubMed  PubMed Central  Google Scholar 

Chan JOS, Baysari MT, Carland JE, et al. Barriers and facilitators of appropriate vancomycin use: prescribing context is key. Eur J Clin Pharmacol. 2018;74(11):1523–9.

Article  PubMed  Google Scholar 

Abdulla A, van den Broek P, Ewoldt TMJ, et al. Barriers and facilitators in the clinical implementation of beta-lactam therapeutic drug monitoring in critically Ill patients: a critical review. Ther Drug Monit. 2022;44(1):112–20.

Article  PubMed  Google Scholar 

Gregory ER, Burgess DR, Cotner SE, et al. Vancomycin area under the curve dosing and monitoring at an academic medical center: transition strategies and lessons learned. J Pharm Pract. 2020;33(6):774–8.

Article  PubMed  Google Scholar 

Flottorp SA, Oxman AD, Krause J, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci. 2013;8:35.

Article  PubMed  PubMed Central  Google Scholar 

Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204.

Article  PubMed  PubMed Central  Google Scholar 

Swartling M, Tängdén T, Lipcsey M, et al. Therapeutic drug monitoring of vancomycin and meropenem: illustration of the impact of inaccurate information in dose administration time. Int J Antimicrob Agents. 2023;63(1): 107032.

Article  PubMed  Google Scholar 

Kok G, Gottlieb NH, Peters GJ, et al. A taxonomy of behaviour change methods: an Intervention Mapping approach. Health Psychol Rev. 2016;10(3):297–312.

Article  PubMed  Google Scholar 

Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.

Article  PubMed  Google Scholar 

Smith JD, Li DH, Rafferty MR. The Implementation Research Logic Model: a method for planning, executing, reporting, and synthesizing implementation projects. Implement Sci. 2020;15(1):84.

Article  PubMed  PubMed Central  Google Scholar 

Stocker SL, Carland JE, Reuter SE, et al. Evaluation of a pilot vancomycin precision dosing advisory service on target exposure attainment using an interrupted time series analysis. Clin Pharmacol Ther. 2021;109(1):212–21.

Article  CAS  PubMed  Google Scholar 

Ewoldt TMJ, Abdulla A, Rietdijk WJR, et al. Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive Care Med. 2022;48(12):1760–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frymoyer A, Schwenk H